"countermeasures for viral pathogens. This is a transfer from the department of interior agreement no.: D18AC00002 amend. 0010. That document does not exists in fpds-NG.

Other Transaction IDV Awarded Last action

Contract number
HR00112190034
Awardee
Awarding agency
Task orders
0

Award facts

Last date to order
Not on record
IDV ceiling
$54,863,580.00
Contracting staff
Funding agency
Defense Advanced Research Projects Agency Department of Defense
NAICS code
Not on record
Set-aside
No set-aside
Competition
Competed Broad Agency Announcement
Pricing
Other

Award details come from SAM.gov/FPDS.

About this IDV

This Other Transaction (OT) Indefinite Delivery Vehicle (IDV) was awarded by the Defense Advanced Research Projects Agency (DARPA), a defense agency, to Abcellera Biologics Inc. The $54,863,580.00 contract is for countermeasures against viral pathogens, which was transferred from an earlier Department of Interior agreement. The IDV does not include any set-asides and was awarded on December 1, 2020, with a period of performance that is not specified. The contracted products and services appear to involve the development of viral countermeasures, though the specific details of the requirements and task orders are not provided. As an OT agreement, this contract utilizes an alternative contracting mechanism outside the standard Federal Acquisition Regulation (FAR) framework, affording DARPA greater flexibility in procuring innovative solutions to address emerging threats.

Transactions

Action Obligated Date
Other Administrative Action ARZ999 · Pay office change $0
Other Administrative Action P00025 $0
Other Administrative Action P00024 $0
Other Administrative Action P00023 $0
Other Administrative Action P00022 $0
Other Administrative Action P00021 $0
Other Administrative Action P00020 $17,624,973
Other Administrative Action P00019 $0
Supplemental Agreement for work within scope P00018 · Pandemic prevention platform (P3) $0
Funding Only Action P00017 · Pandemic prevention platform -$1,641,467
Funding Only Action P00016 $1,459,756
Funding Only Action P00015 · Pandemic prevention platform (P3), this is covid-19 related research. $8,659,203
Funding Only Action P00014 $3,004,930
Funding Only Action P00013 $5,921,587
Funding Only Action P00012 · Pandemic prevention platform (P3) $5,650,853
Funding Only Action P00011 · Pandemic prevention platform (P3), this is the first executed DARPA modification to an OT-p transferred from the department of the interior. $4,066,554
Original award $0
Show all 17

Quick answers

Who was awarded contract HR00112190034?

HR00112190034 was awarded to Abcellera Biologics Inc. by Defense Contract Management Agency (Department of Defense) on December 1, 2020.

How much is contract HR00112190034 worth?

HR00112190034's own ceiling is $54,863,580.

Which agency awarded contract HR00112190034?

Defense Contract Management Agency (Department of Defense) awarded HR00112190034, with funding from Defense Advanced Research Projects Agency (Department of Defense).

Was contract HR00112190034 competed?

The extent of competition for HR00112190034 was competed.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV